Your browser doesn't support javascript.
ABSTRACT
Wu et al. report that patients with hematologic malignancies have reduced immunity against SARS-CoV-2 Omicron subvariants and Sotrovimab retains neutralizing capacity against all tested Omicron subvariants.
Search on Google
Collection: Databases of international organizations Database: EuropePMC Topics: Variants Language: English Journal: Cancer cell Year: 2023 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Collection: Databases of international organizations Database: EuropePMC Topics: Variants Language: English Journal: Cancer cell Year: 2023 Document Type: Article